Exagen (NASDAQ:XGN) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Exagen beat estimated earnings by 1.64%, reporting an EPS of $-0.6 versus an estimate of $-0.61.
Revenue was down $193.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 4.42% increase in the share price the next day.
Here's a look at Exagen's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.50 | -0.46 | -0.44 | -0.47 |
| EPS Actual | -0.42 | -0.42 | -0.38 | -0.48 |
| Revenue Estimate | 11.80M | 12.13M | 11.48M | 10.45M |
| Revenue Actual | 12.69M | 12.25M | 12.77M | 10.59M |
To track all earnings releases for Exagen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
